Literature DB >> 14190473

THE 5-HYDROXYTRYPTAMINE CONTENT OF THE PLACENTA AND FOETUS DURING PREGNANCY IN MICE.

J M ROBSON, J B SENIOR.   

Abstract

5-Hydroxytryptamine (5HT) levels were measured in blood and tissues from pregnant mice. Blood levels remained constant during pregnancy and were the same as those in nonpregnant female mice. Placental levels of 5HT increased throughout pregnancy as did the foetal levels. The maternal blood volume of the placenta also increased with advancing gestation. 5HT levels were measured after treatment of the mother with 5HT, and the critical placental level of 5HT observed at about the time of death of the foetus was determined. The levels of 5HT in the placenta and foetus after treatment of the mother with several monoamine oxidase inhibitors were measured, and found to show no significant increase above the normal levels in these tissues. Treatment with cyproheptadine, a 5HT antagonist, did not delay parturition.

Entities:  

Keywords:  BLOOD CHEMICAL ANALYSIS; BLOOD VOLUME DETERMINATION; CYPROHEPTADINE; EXPERIMENTAL LAB STUDY; FETUS; IPRONIAZID; MICE; MONOAMINE OXIDASE INHIBITORS; PHARMACOLOGY; PLACENTA; PREGNANCY; PREGNANCY, ANIMAL; SEROTONIN; TRANYLCYPROMINE

Mesh:

Substances:

Year:  1964        PMID: 14190473      PMCID: PMC1703971          DOI: 10.1111/j.1476-5381.1964.tb02043.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  9 in total

1.  THE EFFECT OF AMINE OXIDASE INHIBITORS ON PREGNANCY.

Authors:  E POULSON; J M ROBSON
Journal:  J Endocrinol       Date:  1963-11       Impact factor: 4.286

2.  Mechanism of lethal action of 5-hydroxytryptamine on the foetus.

Authors:  J M ROBSON; F M SULLIVAN
Journal:  J Endocrinol       Date:  1963-01       Impact factor: 4.286

3.  The effect of 5-hydroxytryptamine on pregnancy.

Authors:  D LINDSAY; E POULSON; J M ROBSON
Journal:  J Endocrinol       Date:  1963-03       Impact factor: 4.286

4.  The onset of labour.

Authors:  A I CSAPO
Journal:  Lancet       Date:  1961-08-05       Impact factor: 79.321

5.  Identification and assay of serotonin in brain.

Authors:  D F BOGDANSKI; A PLETSCHER; B B BRODIE; S UNDENFRIEND
Journal:  J Pharmacol Exp Ther       Date:  1956-05       Impact factor: 4.030

6.  The distribution of substance P and 5-hydroxytryptamine in the central nervous system of the dog.

Authors:  A H AMIN; T B CRAWFORD; J H GADDUM
Journal:  J Physiol       Date:  1954-12-10       Impact factor: 5.182

7.  The relative activities of some tryptamine analogues on the isolated rat stomach strip preparation.

Authors:  J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1959-03

8.  A sensitive method for the assay of 5-hydroxytryptamine.

Authors:  J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1957-09

9.  The enteric distribution of 5-hydroxytryptamine (enteramine, serotonin) in some large domestic mammals and the appearance of 5-hydroxytryptamine and the enterochromaffin cell system in the embryonic calf.

Authors:  R FAUSTINI
Journal:  Am J Vet Res       Date:  1955-07       Impact factor: 1.156

  9 in total
  12 in total

1.  NEW LOOK AT TOXAEMIA OF PREGNANCY.

Authors:  H J LEHMANN
Journal:  Br Med J       Date:  1964-08-22

2.  Effect of some drugs on human umbilical artery in vitro.

Authors:  S D Gokhale; O D Gulati; L V Kelkar; V V Kelkar
Journal:  Br J Pharmacol Chemother       Date:  1966-08

3.  Embryotoxic and teratogenic action of 5-hydroxytryptamine: mechanism of action in the rat.

Authors:  P B Marley; J M Robson; F M Sullivan
Journal:  Br J Pharmacol Chemother       Date:  1967-11

4.  The role of amines in placental function. Monoamine metabolism in pregnancy.

Authors:  M Sandler
Journal:  Proc R Soc Med       Date:  1966-08

5.  The 5-hydroxytryptamine content of the placenta, foetus and some maternal tissues during pregnancy in the rat.

Authors:  I Fahim; J M Robson; J B Senior
Journal:  Br J Pharmacol Chemother       Date:  1966-01

6.  Analysis of actions of 5-hydroxytryptamine in pregnancy.

Authors:  J M Robson; F M Sullivan
Journal:  J Physiol       Date:  1966-06       Impact factor: 5.182

7.  Serotonin homeostasis in the materno-foetal interface at term: Role of transporters (SERT/SLC6A4 and OCT3/SLC22A3) and monoamine oxidase A (MAO-A) in uptake and degradation of serotonin by human and rat term placenta.

Authors:  Rona Karahoda; Hana Horackova; Petr Kastner; Andreas Matthios; Lukas Cerveny; Radim Kucera; Marian Kacerovsky; Jurjen Duintjer Tebbens; Alexandre Bonnin; Cilia Abad; Frantisek Staud
Journal:  Acta Physiol (Oxf)       Date:  2020-05-18       Impact factor: 6.311

8.  Impact of Maternal Serotonin Transporter Genotype on Placental Serotonin, Fetal Forebrain Serotonin, and Neurodevelopment.

Authors:  Christopher L Muller; Allison Mj Anacker; Tiffany D Rogers; Nick Goeden; Elizabeth H Keller; C Gunnar Forsberg; Travis M Kerr; Carly LA Wender; George M Anderson; Gregg D Stanwood; Randy D Blakely; Alexandre Bonnin; Jeremy Veenstra-VanderWeele
Journal:  Neuropsychopharmacology       Date:  2016-08-23       Impact factor: 7.853

9.  Maternal Inflammation Disrupts Fetal Neurodevelopment via Increased Placental Output of Serotonin to the Fetal Brain.

Authors:  Nick Goeden; Juan Velasquez; Kathryn A Arnold; Yen Chan; Brett T Lund; George M Anderson; Alexandre Bonnin
Journal:  J Neurosci       Date:  2016-06-01       Impact factor: 6.167

10.  Inhibition of mechanistic target of rapamycin signaling decreases levels of O-GlcNAc transferase and increases serotonin release in the human placenta.

Authors:  Amy Catherine Kelly; Anita Kramer; Fredrick J Rosario; Theresa L Powell; Thomas Jansson
Journal:  Clin Sci (Lond)       Date:  2020-12-11       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.